Safety Evaluation of Biotechnologically-derived Pharmaceuticals

Facilitating a Scientific Approach

Nonfiction, Reference & Language, Law, Medical Law & Legislation, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Safety Evaluation of Biotechnologically-derived Pharmaceuticals by , Springer Netherlands
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9789401148764
Publisher: Springer Netherlands Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9789401148764
Publisher: Springer Netherlands
Publication: December 6, 2012
Imprint: Springer
Language: English

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

More books from Springer Netherlands

Cover of the book Anesthesia and the Lung by
Cover of the book Protein Biosynthesis by
Cover of the book Physics, Philosophy and Psychoanalysis by
Cover of the book Galileo Engineer by
Cover of the book Quaternary of South-West England by
Cover of the book Motor Vehicle Science by
Cover of the book Citation Classics from the Journal of Business Ethics by
Cover of the book Weathering and the Riverine Denudation of Continents by
Cover of the book Chance Encounters: Probability in Education by
Cover of the book Equality of Treatment and Trade Discrimination in International Law by
Cover of the book Insect Biotechnology by
Cover of the book Nanoscience Advances in CBRN Agents Detection, Information and Energy Security by
Cover of the book Cerebral Damage Before and After Cardiac Surgery by
Cover of the book Developing Learning Professionals by
Cover of the book Agroecological Crop Protection by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy